|
|
|
NeuroStar TMS Therapy may be covered on a case-by-case basis. Patients can work
with their provider and the
NeuroStar Care Connection (NCC) program
to seek case-by-case coverage. The NCC is staffed by trained case managers to help
providers and patients with the reimbursement process. Neuronetics, the developer
of the NeuroStar system, has developed this program to help patients secure coverage
and reimbursement for NeuroStar TMS Therapy.
The NeuroStar Care Connection program is available to all customers and their patients who qualify.
New therapies like NeuroStar TMS Therapy
are often not included in health insurance plans when they first become available
to patients. It usually takes time for health insurance plans to establish coverage
policies for newly approved technologies such as NeuroStar TMS Therapy. The objective
for NeuroStar Care Connection program staff is to assist you in obtaining coverage and
reimbursement for your patients who qualify.
In the mean time, out-of-pocket payment for NeuroStar TMS Therapy is required. NeuroStar
TMS Therapy can be paid from healthcare flexible spending account. Patients can
also work with
Clark Behavioral Health Financing
to develop a financing plan, if needed.
Download the NeuroStar Care Connection Brochure
Download the NeuroStar Care Connection Enrollment Form
Contact Information
NeuroStar Care Connection Program
1650 South Amphlett Blvd, Suite 300
San Mateo, CA 94402
Tel: 1-877 NCC2TMS
(1-877-622-2867)
Fax: 1-866-307-1339
Hours of Operation
Monday–Friday, 10:00 a.m.–7:00 p.m. EST
Closed Holidays
|
|
 |
|
Refer a Patient for Treatment
|
NeuroStar TMS Therapy may be right for your patients suffering from major depression. Refer them here.
Find a Provider
|
|
|
|
Become a NeuroStar TMS Therapy Provider
|
Provide your patients the new way back from depression with NeuroStar TMS Therapy®.
Contact us to find out how you can bring NeuroStar into your workplace.
Contact Us
|
|
|
*
NeuroStar TMS Therapy ® is indicated for the treatment of Major Depressive
Disorder in adult patients who have failed to achieve satisfactory improvement from
one prior antidepressant medication at or above the minimal effective dose and duration
in the current episode. Click here for full prescribing and safety information
|